Physician profile
Thomas G Quinn
NPI 1851351811
$28,728.60
in general payments reported to CMS, 2019-2025
11 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,496 · 2020: $5,050 · 2021: $4,803 · 2022: $6,726 · 2023: $7,181 · 2024: $218 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,875 · Consulting Fee: $2,000 · Travel and Lodging: $1,940 · Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,875.00 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $1,939.73 |
| Food and Beverage | $837.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $10,693.72 | 2019-2023 | Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $6,696.98 | 2019-2021 | |
| Alcon Vision LLC | $5,482.21 | 2019-2025 | Air Optix, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $4,352.57 | 2019-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $783.40 | 2022-2025 | Zenlens, Xiidra, Envista Mx60 Iol |
| Lombart Brothers, INC. | $261.07 | 2019 | |
| Optovue, INC. | $186.00 | 2019 | |
| Glaukos Corporation | $123.76 | 2023-2024 | Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Johnson & Johnson Surgical Vision, INC. | $66.46 | 2023 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Visioneering Technologies, INC. | $53.85 | 2022 | |
| Optos, INC. | $28.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.